Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 oQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31,September 30, 2019

 

 xTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

       TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission File No. 000-18730

 

DARKPULSE, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE 87-0472109
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)

 

350 5th Ave, 59th Fl.

New York, NY

 10118
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:(800) 436-1436

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange
on which registered
NoneN/AN/A

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yesx No¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”filer”, “accelerated filer”, and “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

 Large accelerated fileroAccelerated filero
 Non-accelerated fileroSmaller reporting companyx
 Emerging growth companyo 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso Nox

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbols(s)Name of each exchange on which registered
NoneN/AN/A

 

As of May 15,November 6, 2019, there were 120,668,9141,129,719,021 shares of the Registrant’s common stock, $0.01 par value per share, issued.

 

   

 

 

DARKPULSE, INC.

FORM 10-Q

TABLE OF CONTENTS

 

FOR THE QUARTER ENDED MARCH 31,SEPTEMBER 30, 2019

 

PART I - Financial Information
   
Item 1.  Financial Statements3
   
 Condensed Consolidated Balance Sheets as of March 31,September 30, 2019 (unaudited) and December 31, 20183
 Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended March 31,September 30, 2019 and 2018 (unaudited)4
 Condensed Consolidated Statements of Comprehensive Gain/Loss (unaudited)5
 Condensed Consolidated Statements of Stockholders’ Deficit for the Three Months and Nine Months Ended March 31,September 30, 2019 and 2018 (unaudited)6
 Condensed Consolidated Statements of Cash Flows for the ThreeNine Months Ended March 31,September 30, 2019 and 2018 (unaudited)7
 Notes to Condensed Consolidated Financial Statements (unaudited)8
   
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations1715
   
Item 3.  Quantitative and Qualitative Disclosures About Market Risk17
Item 4.  Controls and Procedures18
PART II - Other Information
Item 1.Legal Proceedings19
Item 1A.  Risk Factors19
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds19
Item 3.  Defaults upon Senior Securities19
   
Item 4.  Controls and Procedures20
PART II - Other Information
Item 1.Legal Proceedings21
Item 1A.  Risk Factors21
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds21
Item 3.  Defaults upon Senior Securities21
Item 4.  Mine Safety Disclosures2119
   
Item 5.  Other Information2119
   
Item 6.  Exhibits2220
   
Signatures2321

 

 

 

 i2 

 

 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

 

DARKPULSE, INC.

Condensed Consolidated Balance Sheets

Unaudited

 

 September 30, December 31, 
 March 31, December 31,  2019  2018 
 2019  2018      
ASSETS                
                
CURRENT ASSETS:                
Cash $135  $72,294  $1,408  $72,294 
Prepaid expenses  746   746   746   746 
TOTAL CURRENT ASSETS  881   73,040   2,154   73,040 
                
Other assets, net  96,141   70,679   116,495   70,679 
Patents, net  478,638   486,932   457,775   486,932 
TOTAL ASSETS $575,660  $630,651  $576,424  $630,651 
                
LIABILITIES AND STOCKHOLDERS' DEFICIT                
                
CURRENT LIABILITIES:                
Accounts payable $75,904  $59,160  $264,185  $59,160 
Convertible notes, net of discount $275,532 and $440,800 respectively  767,846   601,250 
Convertible notes, net of discount $93,138 and $440,800 respectively  928,702   601,250 
Derivative liability  1,017,159   653,831   341,209   653,831 
Accrued liabilities  469,381   343,519   465,337   343,519 
Contract liability, related party  42,000   42,000   42,000   42,000 
Related party notes payable  44,096   44,096   44,096   44,096 
TOTAL CURRENT LIABILITIES  2,416,386   1,743,856   2,085,529   1,743,856 
                
Secured debenture  1,124,294   1,102,243   1,132,965   1,102,243 
TOTAL LIABILITIES  3,540,680   2,846,099   3,218,494   2,846,099 
                
Commitments and contingencies                
                
STOCKHOLDERS' DEFICIT                
Common stock (par value $0.01), 3,000,000,000 and 250,000,000 shares authorized, 102,168,914 and 89,680,567 shares issued and outstanding respectively  1,021,689   896,806 
Common stock (par value $0.01), 3,000,000,000 and 250,000,000 shares authorized, 872,309,164 and 89,680,567 shares issued and outstanding respectively  8,723,092   896,806 
Treasury stock, 100,000 shares  (1,000)  (1,000)  (1,000)  (1,000)
Convertible preferred stock, Series D (par value $0.01) 100,000 shares authorized, 88,235 shares issued and outstanding respectively  883   883   883   883 
Paid in capital in excess of par value  813,644   859,481   (6,703,232)  859,481 
Non-controlling interest in a variable interest entity and subsidiary  (12,439)  (12,439)  (12,439)  (12,439)
Accumulated other comprehensive income  367,630   389,680   358,958   389,680 
Accumulated deficit  (5,155,427)  (4,348,859)  (5,008,332)  (4,348,859)
TOTAL STOCKHOLDERS' DEFICIT  (2,965,020)  (2,215,448)  (2,642,070)  (2,215,448)
                
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $575,660  $630,651  $576,424  $630,651 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

DARKPULSE, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

  FOR THE THREE MONTHS 
  ENDED MARCH 31, 
  2019  2018 
REVENUES $  $ 
         
OPERATING EXPENSES:        
General and administrative expenses  44,606    
Payroll and compensation  168,945    
Amortization of patents  12,757   12,757 
Debt transaction expenses  12,100    
TOTAL OPERATING EXPENSES  238,408   12,757 
         
OPERATING LOSS  (238,408)  (12,757)
         
OTHER INCOME (EXPENSE):        
Interest expense  (168,588)  (12,551)
Loss on convertible notes  (230,304)   
Loss on change in fair market values of derivative liabilities  (169,268)   
TOTAL OTHER EXPENSE  (568,160)  (12,551)
         
NET LOSS  (806,568)  (25,308)
Net Loss attributable to noncontrolling interests in variable interest entity and subsidiary      
Net loss attributable to Company stockholders $(806,568) $(25,308)
         
LOSS PER SHARE:        
Basic and Diluted $(0.01) $(253)
         
WEIGHTED AVERAGE SHARES OUTSTANDING:        
Basic and Diluted  93,619,272   100 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

 

 43 

 

 

DARKPULSE, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
  2019  2018  2019  2018 
             
REVENUES $  $  $  $ 
                 
OPERATING EXPENSES:                
General and administrative expenses  40,453   281,996   144,965   1,911,353 
Payroll and compensation        168,945    
Legal expenses  48,868      96,962    
Amortization of patents  12,757   18,216   38,271   43,730 
Debt transaction expenses        24,900    
                 
TOTAL OPERATING EXPENSES  102,078   300,212   474,043   1,955,083 
                 
OPERATING LOSS  (102,078)  (300,212)  (474,043)  (1,955,083)
                 
OTHER INCOME (EXPENSE):                
Interest expense  (50,649)  (139,961)  (399,895)  (164,990)
Loss on convertible notes  (47,266)  (916,977)  (351,662)  (916,977)
Gain on change in fair market values of derivative liabilities  221,879   689,949   566,127   689,949 
Loss on merger     (110,685)     (110,685)
                 
TOTAL OTHER INCOME (EXPENSE)  123,964   (477,674)  (185,430)  (502,703)
                 
NET INCOME (LOSS)  21,886   (777,886)  (659,473)  (2,457,786)
Net loss attributable to noncontrolling interests in variable interest entity and subsidiary     100      11,172 
Net income (loss) attributable to Company stockholders $21,886  $(777,786) $(659,473) $(2,446,614)
                 
GAIN (LOSS) PER SHARE:                
Basic and Diluted $0.00  $(0.00) $(0.00) $(0.03)
                 
WEIGHTED AVERAGE SHARES OUTSTANDING:                
Basic and Diluted  518,604,087   89,680,567   252,457,517   76,127,111 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

DARKPULSE, INC.

Condensed Consolidated Statements of Comprehensive Gain/Loss

(Unaudited)

 

 FOR THE THREE MONTHS  FOR THE THREE MONTHS FOR THE NINE MONTHS 
 ENDED MARCH 31,  ENDED SEPTEMBER 30, ENDED SEPTEMBER 30, 
 2019  2018  2019  2018  2019  2018 
              
NET LOSS $(806,568) $(25,308)
NET INCOME (LOSS) $21,886  $(777,786) $(659,473) $(2,446,614)
                        
OTHER COMPREHENSIVE GAIN (LOSS)                        
Unrealized Gain (Loss) on Foreign Exchange  (22,050)  29,886   12,671   (20,638)  (30,722)  29,359 
COMPREHENSIVE GAIN (LOSS) $(828,618) $4,578  $34,557  $(798,424) $(690,195) $(2,417,255)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

DARKPULSE, INC.

Consolidated Statement of Stockholders' Deficit

For the Periods Ended September 30, 2019 and 2018

 Preferred Stock Common Stock Treasury Paid in
Capital in
Excess
of Par
 Non-
Controlling Interest in
 Accumulated Other Comprehensive Accumulated Total Stockholders’ 
 Shares Amount Shares Amount Stock Value Subsidiary Income Deficit Deficit 
                     
Balance, December 31, 2018 88,235 $883  89,680,467 $896,806 $(1,000)$859,481 $(12,439)$389,680 $(4,348,859)$(2,215,448)
Conversion of convertible notes     12,488,347  124,883    (45,837)       79,046 
Foreign currency adjustment               (22,050)    (22,050)
Net loss                 (806,568) (806,568)
Balance, March 31, 2019 88,235 $883  102,168,914 $1,021,689 $(1,000)$813,644 $(12,439)$367,630 $(5,155,427)$(2,965,020)
Conversion of convertible notes     137,005,692  1,370,057    (1,284,135)       85,922 
Foreign currency adjustment               (21,343)    (21,343)
Net gain (loss)                 125,210  125,210 
Balance, June 30, 2019 88,235 $883  239,174,606 $2,391,746 $(1,000)$(470,491)$(12,439)$346,287 $(5,030,217)$(2,775,231)
Conversion of convertible notes     633,134,558  6,331,346    (6,232,741)       98,605 
Foreign currency adjustment               12,671     12,671 
Net gain (loss)                 21,886  21,886 
Balance, September 30, 2019 88,235 $883  872,309,164 $8,723,092 $(1,000)$(6,703,232)$(12,439)$358,958 $(5,008,332)$(2,642,069)
                               
                               
Balance, December 31, 2017  $  100 $ $ $ $25,808 $298,908 $(1,030,800)$(706,084)
Foreign currency adjustment               29,886     29,886 
Net loss                 (25,308) (25,308)
Balance, March 31, 2018  $  100 $ $ $ $25,808 $328,794 $(1,056,108)$(701,506)
Foreign currency adjustment               20,111    20,111 
Net loss                 (24,231) (24,231)
Balance, June 30, 2018  $  100 $ $ $ $25,808 $348,905 $(1,080,339)$(705,626)
Recapitalization of the Company 88,235  883  89,680,467  896,806  (1,000) 859,481  (38,247)   (1,630,461) 87,462 
Foreign currency adjustment               (20,637)   (20,637)
Net loss                 (777,786) (777,786)
Balance, September 30, 2018 88,235 $883  89,680,567 $896,806 $(1,000)$859,481 $(12,439)$328,268 $(3,488,586)$(1,416,587)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

DARKPULSE, INC.

Condensed Consolidated Statement of Cash Flows

(Unaudited)

  FOR THE NINE MONTHS 
  ENDED SEPTEMBER 30, 
  2019  2018 
       
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net Loss $(659,473) $(2,457,786)
Adjustments to reconcile net loss to net cash used by operating activities:        
Depreciation and amortization  38,271   45,536 
Loan acquisition costs  24,900    
Stock based compensation     1,602,570 
Interest on notes payable  27,446    
Debt discount  (205,000)  205,406 
Amortization of debt discount  568,985    
Derivative liability  (312,622)  115,678 
Changes in operating assets and liabilities:        
Accounts payable  205,025   54,153 
Contract liabilities     42,000 
Accrued liabilities  110,340   138,540 
Cash held by officer of VIE     10,650 
Prepaid expenses     (746)
Net cash used by operating activities  (202,128)  (243,999)
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Noncontrolling interest     (38,247)
Investment in patents  (54,930)  (141,223)
Net Cash Used by Investing Activities  (54,930)  (179,470)
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible notes payable  180,100   572,072 
Payments on convertible notes and interest  (24,650)  (8,050)
Proceeds from related party payable     44,096 
Payments on note payable     (33,386)
Net Cash Provided by Financing Activities  155,450   574,732 
         
Effect of exchange rate on cash  30,722    
         
NET INCREASE (DECREASE) IN CASH  (70,886)  151,263 
         
CASH, beginning of period  72,294   8,025 
CASH, end of period $1,408  $159,288 
         
Noncash investing and financing activities for the quarter ending September 30:        
Stock issued for convertible notes payable and accrued interest $232,535  $ 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest paid in cash $66,850  $ 
Taxes paid in cash $  $ 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

 

5

DARKPULSE, INC.

Consolidated Statement of Stockholders' Deficit

For the Years Ended March 31, 2019 and 2018

  Preferred Stock  Common Stock  Treasury  Paid in
Capital in
Excess of
Par
  Non-Controlling Interest in  Accumulated Other Comprehensive  Accumulated  Total Stockholders’ 
  Shares  Amount  Shares  Amount  Stock  Value  Subsidiary  Income  Deficit  Deficit 
Balance, December 31, 2018  88,235  $883   89,680,467  $896,806  $(1,000) $859,481  $(12,439) $389,680  $(4,348,859) $(2,215,448)
Conversion of convertible notes        12,488,347   124,883      (45,837)           79,046 
Foreign currency adjustment                       (22,050)      (22,050)
Net loss                          (806,568)  (806,568)
Balance, March 31, 2019  88,235  $883   102,168,914  $1,021,689  $(1,000) $813,644  $(12,439) $367,630  $(5,155,427) $(2,965,020)
                                         
Balance, December 31, 2017    $   100  $  $  $  $25,808  $298,908  $(1,030,800) $(706,084)
Foreign currency adjustment                       29,886      29,886 
Net loss                          (25,308)  (25,308)
Balance, March 31, 2018    $   100  $  $  $  $25,808  $328,794  $(1,056,108) $(701,506)

6

DARKPULSE, INC.

Condensed Consolidated Statement of Cash Flows

(Unaudited)

  FOR THE THREE MONTHS 
  ENDED MARCH 31, 
  2019  2018 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net Loss $(806,568) $(25,308)
Adjustments to reconcile net loss to net cash used by operating activities:        
Depreciation and amortization  12,757   12,757 
Loan acquisition costs  12,100   -- 
Interest on notes payable  35,564   12,551 
Debt discount  (100,000)  -- 
Amortization of debt discount  269,268    
Derivative liability  363,328    
Changes in operating assets and liabilities:        
Accounts payable  16,744    
Accrued liabilities  91,323    
Net cash used by operating activities  (105,484)   
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Investment in patents  (29,925)   
Net Cash Used by Investing Activities  (29,925)   
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible notes payable  87,900    
Payments on convertible notes  (24,650   
Net Cash Provided by Financing Activities  63,250    
         
NET INCREASE (DECREASE) IN CASH  (72,159   
CASH, beginning of period  72,294    
CASH, end of period $135  $ 
         
Noncash investing and financing activities for the quarter ending March 31:        
Stock issued for convertible notes payable and accrued interest $78,022  $ 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest paid in cash $  $ 
Taxes paid in cash $  $ 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 7 

 

 

DARKPULSE, INC.

Notes to Condensed Financial Statements

(Unaudited)

 

NOTE 1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial statements and do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The consolidated financial statements as of December 31, 2018 have been audited by an independent registered public accounting firm. The accounting policies and procedures employed in the preparation of these condensed consolidated financial statements have been derived from the audited financial statements of the Company for the year ended December 31, 2018, which are contained in Form 10-K as filed with the Securities and Exchange Commission on April 16,2019. The consolidated balance sheet as of December 31, 2018 was derived from those financial statements.

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the U.SU.S. Securities and Exchange Commission for Interim Financial Information. The condensed consolidated financial statements of the Company include the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s financial position as of March 31,September 30, 2019, and the results of operations and cash flows for the threenine months ended March 31,September 30, 2019 have been included. The results of operations for the three and nine months ended March 31,September 30, 2019 are not necessarily indicative of the results to be expected for the full year.

 

Description of Business

 

DarkPulse, Inc. ("DPI" or "Company") is a technology-security company incorporated in 1989 as Klever Marketing, Inc. ("Klever"). Its’The Company’s wholly-owned subsidiary, DarkPulse Technologies Inc. ("DPTI"), was originally startedformed as a privately held technology spinout from the University of New Brunswick, Fredericton, Canada. The Company’sCompany plans for its security and monitoring systems willto initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision.The Company’s patented BOTDA dark-pulse sensor technology allows for the monitoring of highly dynamic environments due to its greater resolution and accuracy.

 

On April 27, 2018, Klever entered into an Agreement and Plan of Merger (the “Merger Agreement” or the “Merger”) involving Klever as the surviving parent corporation and acquiring a privately held New Brunswick corporation known as DarkPulse Technologies Inc.DPTI as its wholly owned subsidiary.subsidiary (the “Merger”). On June 29, 2018, the parties entered into Amendment No. 1 to the Merger Agreement, and on July 18, 2018 the parties closed the Merger Agreement, as amended on July 7, 2018, and the name of the Company was subsequently changed to DarkPulse, Inc.Merger. With the change of control of the Company, the Merger is being bewas accounted for as a recapitalization in a manner similar to a reverse acquisition.

 

On July 20, 2018, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware changing the name of the Company to DarkPulse, Inc. The Company filed a corporate action notification with the Financial Industry Regulatory Authority (FINRA), and the Company's ticker symbol was changed to DPLS.

 

Going Concern Uncertainty

As shown in the accompanying financial statements, during the three months ended September 30, 2019, the Company did not generate any revenues and reported a net gain of $21,886. As of September 30, 2019, the Company’s current liabilities exceeded its current assets by $2,083,374. As of September 30, 2019, the Company had $1,408 of cash.

 

 

 8 

 

 

Going Concern Uncertainty

As shown in the accompanying financial statements, during the 3 months ended March 31, 2019, the Company did not generate any revenues and reported a net loss of $806,568. As of March 31, 2019, the Company’s current liabilities exceeded its current assets by $2,415,505. As of March 31, 2019, the Company had $135 of cash.

The Company will require additional funding during the next sixnine months to finance the growth of its operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements and expansion of its operations. The accompanying financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations. However, management cannot make any assurances that such financing will be secured.

 

Use of Estimates

 

In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the statements of financial condition, and revenues and expenses for the years then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to, the assumptions used to calculate stock-based compensation, derivative liabilities, preferred deemed dividend and common stock issued for services.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with a high credit quality financial institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. 

 

Intangible Assets

 

The Company reviews intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.

 

Foreign Currency Translation

 

The company translates monetary assets and liabilities (any item paid for or settled in foreign currency) into the United States Dollar at exchange rates prevailing on the balance sheet date. Non-monetary assets and liabilities are translated at the historical rate in effect when the transaction occurred. Revenues and expenses are translated at the spot rate on the date the transaction occurred. Exchange gains and losses from the translation of monetary items are included in unrealized gain/loss on Foreign Exchange as Other Comprehensive Loss.

 

9

The following table discloses the dates and exchange rates used for converting Canadian Dollar amounts to U.S. Dollar amounts disclosed in the balance sheet and the statement of operations.

 

The spot exchange rate between the Canadian Dollar and the U.S. Dollar on December 31, 2018 closing rate at 1.3642 US$: CAD, average rate at 1.2958 US$: CAD and for the three and nine months ended March 31,September 30, 2019 closing rate at 1.33421.3209 US$: CAD, average rate at 1.32921.3294 US$.

9

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740.

 

ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Accounting for Derivatives

 

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, and accruals approximate their fair values because of the short maturity of these instruments. The Company believes the carrying value of its secured debenture payable approximates fair value because the terms were negotiated at arms length.

 

Recent Accounting Pronouncements

 

There were no new accounting pronouncements issued or proposed by the Financial Accounting Standards Board during the threenine months ended March 31,September 30, 2019, and through the date of filing of this report that the Company believes has had or will have a material impact on its financial position or results of operations, including the recognition of revenue, cash flow, the merger that was consummated on July 18, 2018.flows or disclosures. The Company has no lease obligations.

10

 

Income (Loss) Per Common Share

 

Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share of common stock is computed by dividing net income (loss) by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding convertible preferred stock and stock options.

 

10

For the threenine months ended March 31,September 30, 2019, there were no stock options nor convertible preferred stock outstanding. For the threenine months ended March 31,September 30, 2019, common stock equivalents related to convertible preferred stock and convertible debt have not been included in the calculation of diluted loss per common share because they are anti-dilutive. Therefore, basic loss per common share is the same as diluted loss per common share. There are 2,867,409,7861,277,690,836 common shares reserved for the potential conversion of the Company's convertible debt.

 

NOTE 2 - DEBENTURE

 

DPTI issued a convertible Debenture to the University in exchange for the Patents assigned to the Company, in the amount of Canadian $1,500,000, or US $1,491,923 on December 16, 2010, the date of the Debenture. On April 24, 2017 DPTI issued a replacement secured term Debenture in the same C$1,500,000 amount as the original Debenture. The interest rate is the Bank of Canada Prime overnight rate plus 1% per annum. The Debenture had an initial required payment of Canadian $42,000 (US$33,385) due on April 24, 2018 for reimbursement to the University of its research and development costs, and this has been paid. Interest-only maintenance payments are due annually starting after April 24, 2018. Payment of the principal begins on the earlier of (a) three years following two consecutive quarters of positive earnings before interest, taxes, depreciation and amortization, (b) six years from April 24, 2017, or (c) in the event DPTI fails to raise defined capital amounts or secure defined contract amounts by April 24 in the years 2018, 2019, and 2020. The Company has raised funds in excess of the amount required by April 24, 2018. The principal repayment amounts will be due quarterly over a six year period in the amount of Canadian Dollars $62,500. Based on the exchange rate between the Canadian Dollar and the U.S. Dollar on March 31,September 30, 2019, the quarterly principal repayment amounts will be US$46,846.49,644. The Debenture is secured by the Patents assigned by the University to DPTI by an Assignment Agreement on December 16, 2010. DPTI has pledged the Patents, and granted a lien on them pursuant to an Escrow Agreement dated April 24, 2017, between DPTI and the University.

 

The Debenture was initially recorded at the $1,491,923 equivalent US Dollar amount of Canadian $1,500,000 as of December 16, 2010, the date of the original Debenture. The liability is being adjusted quarterly based on the current exchange value of the Canadian dollar to the US dollar at the end of each quarter. The adjustment is recorded as unrealized gain or loss in the change of the value of the two currencies during the quarter. The amounts recorded as an unrealized gain (loss) for the three months ended March 31,September 30, 2019 and 2018, were ($22,050)$12,671 and $29,886($20,638) respectively. These amounts are included in Accumulated Other Comprehensive Loss in the Equity section of the consolidated balance sheet, and as Unrealized Loss on Foreign Exchange on the consolidated statement of comprehensive loss. The Debenture also includes a provision requiring DPTI to pay the University a two percent (2%) royalty on sales of any and all products or services which incorporate the Patents for a period of five (5) years from April 24, 2018.

 

For the three months ended March 31September 30, 2019, and 2018, the Company recorded interest expense of $21,651$12,745 and $12,551, respectively.

 

As of March 31,September 30, 2019 the debenture liability totaled $1,124,294,$1,132,965, all of which was long term.

11

 

Future minimum required payments over the next 5 years and thereafter are as follows:

 

Period ending March 31,    
 2020  $ 
 2021    
 2022    
 2023    
 2024 and after   1,124,294 
 Total  $1,124,294 
Period ending September 30,   
2020 $ 
2021   
2022   
2023   
2024 and after  1,132,965 
Total $1,132,965 

 

NOTE 3 – CONVERTIBLE DEBT SECURITIES

 

The Company uses the Black-Scholes Model to calculate the derivative value of its convertible debt. The valuation result generated by this pricing model is necessarily driven by the value of the underlying common stock incorporated into the model. The values of the common stock used were based on the price at the date of issue of the debt security as of March 31,September 30, 2019. Management determined the expected volatility between 320.82-442.87%318.38-487.51%, a risk free rate of interest between 2.27-2.408%1.75-1.92%, and contractual lives of the debt varying from six months to two years. The table below details the Company's nine outstanding convertible notes, with totals for the face amount, amortization of discount, initial loss, change in the fair market value, and the derivative liability.

 

  Face  Amortization  Initial  Q1 change  Derivative Balance 
  Amount  of Discount  Loss  in FMV  3/31/2019 
  $90,228  $46,788  $58,959  $(38,166) $106,865 
   162,150   49,562   74,429   53,598   195,064 
   90,500   26,886   11,381   (78,377)   
   247,500   50,034      102,626   225,664 
   100,000   32,967   8,904   16,327   91,490 
   103,000   35,517   5,651   47,076   124,475 
   65,000   16,027   28,566   (5,576)  80,890 
   35,000   8,630   16,558   (2,090)  44,468 
   29,250   557      26,144   28,907 
   49,726   947      44,888   49,143 
   41,774   796      37,710   41,285 
   29,250   557      26,144   28,908 
Subtotal  1,043,378   269,268   204,448   230,304   1,017,159 
Transaction expense               
  $1,043,378  $269,268  $204,448  $230,304  $1,017,159 

On January 10, 2019, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, ("GS Capital") issuing to GS Capital a convertible promissory note in the aggregate principal amount of $65,000 with a $4,000 original issue discount and $3,100 in transactional expenses due to GS Capital and its counsel. The note bears interest at 8% per annum and may be converted into common shares of the Company's common stock at a conversion price equal to 70% of the average of the three lowest trading prices of the Company's common stock during the 20 prior trading days. As of the date the consolidated financial statements were available for issuance, DPI received $57,900 net cash.

 

 

 1211 

 

  

  Face  Amortization  Initial  Q3 change  Derivative
Balance
 
  Amount  of Discount  Loss  in FMV  9/30/2019 
  $90,228  $  $58,959  $(67,989) $ 
   162,150      74,429   (128,965)   
   75,652      11,381       
   208,436             
   79,622      8,904       
   65,372      5,651       
   55,180   12,344   28,566   (7,305)  62,544 
   33,194   6,647   16,558   (3,934)  33,677 
   29,250   367      (340)  28,368 
   49,726   624      (579)  48,226 
   41,774   524      (486)  40,514 
   29,250   367      (340)  28,368 
   40,000   10,055   10,605   (4,593)  38,274 
   64,000   16,339   17,676   (7,348)  61,238 
Subtotal  1,023,834   47,266   232,729   (221,879)  341,209 
Transaction expense               
  $1,023,834  $47,266  $232,729  $(221,879) $341,209 

On February 12,

During the three months ended September 30, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, LLC, (“Crown Bridge”) issuing to Crown Bridge a convertible promissory notetotal of $70,696 in the aggregate principal amount of $35,000 with a $3,500 original issue discount and $1,500$10,070 in transactional expenses due to Crown Bridge and its counsel. The note bears interest at 8% per annum and may bewere converted into common633,134,558 shares of the Company'sCompany’s common stock at a conversion price equal to 70% of the lowest trading price of the Company's common stock during the 20 prior trading days. The Company received $30,000 net cash.stock.

  

As of March 31,September 30, 2019 and 2018 respectively, there was $767,846$928,702 and $0 of convertible debt outstanding, net of debt discount of $275,532,$93,138, and $0, As of March 31,September 30, 2019 and 2018 respectively, there was derivative liability of $1,017,159$341,209 and $0 related to convertible debt securities.

 

NOTE 4 - STOCKHOLDERS' DEFICIT

 

As of March 31,September 30, 2019, there were 102,168,914872,309,164 shares of common stock and 88,235 shares of preferred stock issued and outstanding.

 

NOTE 5 - COMMITMENTS & CONTINGENCIES

 

Potential Royalty Payments

 

The Company, in consideration of the terms of the debenture to the University of New Brunswick, shall pay to the University a two percent royalty on sales of any and all products or services which incorporate the Company's patents for a period of five years from April 24, 2018.

 

Potential Commission Payments

 

The Company, in consideration of the Strategic Alliance Agreement with Bravatek, for the purpose of promoting the Company’s products, will pay Bravatek sales commissions for clients introduced to the Company by Bravatek.

 

Legal Matters

 

On March 27, 2019, Thomas A. Cellucci, et al. v. DarkPulse, Inc. et al. (the “Complaint”) was filed in the United States District Court for the Southern District of New York by certain of the Company’s former executive officers, one also being a former director, and a non-employee shareholder (collectively, the “Plaintiffs”), against the Company, its sole officer and director, and others, claiming that the Plaintiffs brought the action to protect their individual rights as minority shareholders, as improperly-ousted officers (other than the non-employee shareholder), and as an improperly-ousted director, seeking equitable relief, damages, recovery of unpaid salaries and other relief. It is the Company's position that the Complaint represents a frivolous harassment lawsuit, and the Company intends to filehas filed a motion to dismiss all claims made in the Complaint and intends to otherwise defend itself vigorously in this matter. The Company is also exploring filing counterclaims against the Plaintiffs in the action.

12

 

From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on our business, financial condition and operating results.

13

 

NOTE 6 – INTANGIBLE ASSETS

 

Intangible Assets - Intrusion Detection Intellectual Property

 

The Company relies on patent laws and restrictions on disclosure to protect its intellectual property rights. As of March 31, 2019, the Company held 3 U.S. and foreign patents on its intrusion detection technology, which expire in calendar years 2025 through 2034 (depending on the payment of maintenance fees).

 

The DPTI issued patents cover a System and Method for Brillouin Analysis, a System and Method for Resolution Enhancement of a Distributed Sensor, and a Flexible Fiber Optic Deformation System Sensor and Method. Maintenance of intellectual property rights and the protection thereof is important to our business. Any patents that may be issued may not sufficiently protect the Company's intellectual property and third parties may challenge any issued patents. Other parties may independently develop similar or competing technology or design around any patents that may be issued to the Company. The Company cannot be certain that the steps it has taken will prevent the misappropriation of its intellectual property, particularly in foreign countries where the laws may not protect proprietary rights as fully as in the United States. Further, the Company may be required to enforce its intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial costs and diversion of management's attention. Additionally, there may be existing patents of which the Company is unaware that could be pertinent to its business, and it is not possible to know whether there are patent applications pending that the Company's products might infringe upon, since these applications are often not publicly available until a patent is issued or published.

 

For the three months ended March 31,September 30, 2019 and 2018, the Company amortized $12,757, respectively. Future amortization of intangible assets is as follows:

 

 2019  $38,271 
 2020   51,028 
 2021   51,028 
 2022   51,028 
 2023   51,028 
 Thereafter   236,255 
    $478,638 
2019 $12,757 
2020  51,028 
2021  51,028 
2022  51,028 
2023  51,028 
Thereafter  236,805 
  $453,674 

 

NOTE 7 – RELATED PARTY TRANSACTIONS

 

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

 

 

 1413 

 

 

In May 2018, DarkPulse BVTK, LLC (the “JV Entity”)the JV Entity received $42,000 for an order from Bravatek Solutions, Inc. ("Bravatek")Bravetek and the JV Entity then placed a corresponding order with the Company. AThe Company’s former executive officer of the Companyoffice is also the CEO of Bravatek. The proceeds were to be used for marketing efforts to generate sales of our intrusion detection product. The order has been recorded as a prepaid sale and is a current liability as of March 31,September 30, 2019.

 

NOTE 8 – PREFERRED STOCK

 

In accordance with the Company’s bylaws, the Company has authorized a total of 2,000,000 shares of preferred stock, par value $0.01 per share, for all classes. As of MarchSeptember 30, 2019, and December 31, 2018, there were 88,235 total preferred shares issued and outstanding for all classes.

 

On July 12, 2018, the Company filed a Certificate of Designation with the State of Delaware amending the designation of its previously designated “Class D Voting Preferred Stock,” designating 100,000 shares of the Company’s preferred stock as “Series D Preferred Stock.” Each share of Series D Preferred Stock entitles the holder to 6,000 votes on all matters submitted to a vote of the Company’s stockholders and is convertible at the election of the holder into a number of shares of common stock equal to the number of outstanding shares of common stock of the Company multiplied by 5 ⅔, divided by the number of outstanding shares of Series D Preferred Stock. All of these shares are owned by the Company's management, with control ownership held by the Company's CEO.

 

NOTE 9 – COMMON STOCK

 

In accordance with the Company’s bylaws, the Company has authorized a total of 3,000,000,000 shares of common stock, par value $0.01 per share. As of March 31,September 30, 2019 and December 31, 2018 respectively, there were 102,168,914872,309,164 and 89,680,567 common shares issued and outstanding.

 

During the three months ended March 31,September 30, 2019, the Company issued 12,488,347633,134,558 shares of common stockas settlement of convertible notes payable and interest in the total amount of $78,022.$80,766.

 

NOTE 10 – STOCK OPTIONS

 

The Company’s shareholders approved, by a majority vote, the adoption of the 1998 Stock Incentive Plan (the “Plan”). As amended on August 11, 2003, the Plan reserves 20,000,000 shares of common stock for issuance upon the exercise of options which may be granted from time-to-time to officers, directors, certain employees and consultants of the Company or its subsidiaries by the Board of Directors. The Plan permits the award of both qualified and non-qualified incentive stock options.

 

During the three months ended March 31,September 30, 2019, the Company did not issue any stock options and had no stock options outstanding at March 31,September 30, 2019.

15

 

NOTE 11 – SUBSEQUENT EVENTS

 

The Company evaluated events occurring after the date of the accompanying unaudited condensed consolidated balance sheets through the date the financial statements were issued and has identified the followingCompany does not have any subsequent events that it believes require disclosure:

On April 17, 2019, the Board of Directors of the Company appointed Dr. Anthony Brown as a director of the Company to fill a vacancy in accordance with the Delaware General Corporation Law (the “DGCL”) and the Company’s Bylaws. In addition, on April 19, 2019, the Board of Directors of the Company appointed Carl Eckel as a director of the Companybe disclosed prior to fill a vacancy in accordance with the DGCL and the Company’s Bylaws.

On May 2, 2019, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc. (“Geneva”) pursuant to which the Company issued to Geneva a convertible promissory note (the “Geneva Note”) in the aggregate principal amount of $64,000, with a $6,000 original issue discount and $2,800 in expenses for Geneva’s legal and due diligence fees, resulting in a purchase price of $55,200. The Geneva Note bears interest at 9% per annum and may be converted into common shares of the Company's common stock at a conversion price equal to 70% of the lowest trading price of the Company's common stock during the 20 prior trading days. The Company received $55,200 net cash on May 2, 2019 in consideration of the issuance of the Geneva Note to Geneva.this filing.

 

 

 

 

 

 

 

 1614 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Background

 

DarkPulse, Inc. ("DPI" or "Company") is a technology-security company incorporated in 1989 as Klever Marketing, Inc. ("Klever"). Its’The Company’s wholly-owned subsidiary, DarkPulse Technologies Inc. ("DPTI"), was originally startedformed as a privately held technology spinout from the University of New Brunswick, Fredericton, Canada. The Company’sCompany plans for its security and monitoring systems willto initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision.The Company’s patented BOTDA dark-pulse sensor technology allows for the monitoring of highly dynamic environments due to its greater resolution and accuracy.

 

On April 27, 2018, Klever entered into an Agreement and Plan of Merger (the “Merger Agreement” or the “Merger”) involving Klever as the surviving parent corporation and acquiring a privately held New Brunswick corporation known as DarkPulse Technologies Inc.DPTI as its wholly owned subsidiary.subsidiary (the “Merger”). On June 29, 2018, the parties entered into Amendment No. 1 to the Merger Agreement, and on July 18, 2018 the parties closed the Merger Agreement, as amended on July 7, 2018, and the name of the Company was subsequently changed to DarkPulse, Inc.Merger. With the change of control of the Company, the Merger is beingwas be accounted for as a recapitalization in a manner similar to a reverse acquisition.

 

On July 20, 2018, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware, changing the name of the Company to DarkPulse, Inc. The Company filed a corporate action notification with the Financial Industry Regulatory Authority (FINRA), and the Company's ticker symbol was changed to DPLS.

 

Going Concern Uncertainty

 

As shown in the accompanying financial statements, during the 3three months ended March 31,September 30, 2019, the Company did not generate any revenues and reported a net lossgain of $806,568.$21,886. As of March 31,September 30, 2019, the Company’s current liabilities exceeded its current assets by $2,415,505.$2,083,374. As of March 31,September 30, 2019, the Company had $135$1,408 of cash.

 

The Company will require additional funding during the next sixnine months to finance the growth of its operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements and expansion of its operations. The accompanying financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations. However, management cannot make any assurances that such financing will be secured.

 

Results of Operations for the Three and Nine Months Ended September 30, 2019 compared to the Three and Nine Months Ended September 30, 2018

 

Revenues

 

To date, the Company has not generated any operating revenues.

 

Operating Expenses

 

General and administrative expenses for the three months ended March 31,September 30, 2019, increaseddecreased by $44,606$241,543 to $44,606$40,453 from $0$281,996 for the three months ended March 31,September 30, 2018. During the three months ended March 31,September 30, 2019, the Company continued to actively preparing to commercialize its patented technology. During the three months ended March 31,September 30, 2018, there were no revenues and all expenses during that time were related to the Company's patented technology.

 

 

 

 1715 

 

 

PayrollGeneral and administrative expenses for nine months ended September 30, 2019, decreased by $1,766,388 to $144,965 from $1,911,353 for the nine months ended September 30, 2018. During the nine months ended September 30, 2019, the Company continued to actively preparing to commercialize its patented technology. During the nine months ended September 30, 2018, there were no revenues and all expenses during that time were related to the Company's patented technology.

The Company had no payroll and compensation expenses for three months ended March 31,September 30, 2019 increased by $168,945 to $168,945 from $0 for the three months ended March 31,or September 30, 2018. The Company expects a significant reduction in payroll related expenses for the remainder of 2019 because it terminated four employees during March 2019.

 

Payroll and compensation expenses for the nine months ended September 30, 2019 increased to $168,945 compared to $0 for the nine months ended September 30, 2018. The Company expects a significant reduction in payroll related expenses for the remainder of 2019 because it terminated four employees during March 2019.

Legal expense for three months ended September 30, 2019 increased to $48,868 from $0 for the three months ended September 30, 2018. Legal expense for nine months ended September 30, 2019 increased $96,962 from $0 for the nine months ended September 30, 2018.

Amortization of patents expense for three months ended March 31,September 30, 2019 remained the same atdecreased $5,459 to $12,757 from $18,216 for the three months ended March 31,September 30, 2018. Amortization of patents expense for nine months ended September 30, 2019 decreased $5,459 to $38,271 from $43,730 for the nine months ended September 30, 2018.

 

Other Income (Expense)

 

Interest expense was $168,588$50,649 and $12,551$139,961 for the three months ended March 31,September 30, 2019 and 2018, respectively. This increase is primarily related to an increase in notes payable.

Interest expense was $399,895 and $164,990 for the nine months ended September 30, 2019 and 2018, respectively. This increase is primarily related to an increase in notes payable.

 

Loss on convertible notes expense was $230,304$47,266 for the three months ended March 31, 2019. LossSeptember 30, 2019 compared to $916,977 for the three months ended September 30, 2018. Gain on change in fair market value of derivative liabilities was $169,268$221,879 for the three months ended March 31, 2019.September 30, 2019 compared to $689,949 for the three months ended September 30, 2018.

Loss on convertible notes expense was $351,662 for the nine months ended September 30, 2019 compared to $916,977 for the nine months ended September 30, 2018. Gain on change in fair market value of derivative liabilities was $566,127 for the nine months ended September 30, 2019 compared to $689,949 for the nine months ended September 30, 2018.

 

Provision for Income Taxes

 

The provision for income taxes was $0 and $0 for the three and nine months ended March 31,September 30, 2019 and 2018, respectively.

 

Net Income (Loss)

 

As a result of the above, we reported a net income of $123,964 and a net loss of $806,568 and $25,308$477,674 for the three months ended March 31,September 30, 2019 and 2018, respectively.

Additionally as a result of the above, we reported a net loss of $185,430 and a net loss of $502,703 for the nine months ended September 30, 2019 and 2018, respectively.

16

 

Liquidity and Capital Resources

 

The Company requires working capital to fund the further development and commercialization of its proprietary fiber optic sensing devices, and for operating expenses. During the three months ended March 31, 2019, the Company received cash proceeds from the issuance of convertible debt securities in the amount of $87,900.

 

As of March 31,September 30, 2019, we had cash of $135,$1,408, compared to $72,294 as of December 31, 2018. As of March 31,September 30, 2019, our current liabilities exceeded our current assets by $2,415,505.$2,083,374.

 

Cash Flows From Operating Activities

 

During the threenine months ended March 31,September 30, 2019, net cash used by operating activities was $105,484,$202,128, resulting from our net loss of $806,568$659,473 and an increase in expenses related to our convertible notes payables, including amortization of debt discount of $269,268,$568,985, debt discount of $100,000,$205,000, increases in accounts payable of $16,744$205,025 and accrued liabilities of $91,323.$110,340.

 

By comparison, during the threenine months ended March 31,September 30, 2018, net cash used by operating activities was $0,$243,999, resulting from our net loss of $25,308 offset by an increase in accrued interest of $12,551,$2,457,786 and an increase in amortization expenseexpenses related to stock based compensation of $1,602,570 as well our convertible notes payables, including debt discount of $205,406, increases in the amountaccounts payable of $12,757.$54,153 and accrued liabilities of $138,540.

18

 

Cash Flows From Investing Activities

 

During the three months ended March 31,September 30, 2019, the Company used $29,925$54,930 in investing activities, relatingall of which was related to our patents and trademarks in the amount of $29,925.trademarks. During the three months ended March 31,September 30, 2018, Company had no net cash provided by or used $179,470 in investing activities.activities of which $141,223 was related to our patents and trademarks.

 

Cash Flows From Financing Activities

 

During the threenine months ended March 31,September 30, 2019, net cash provided by financing activities was $63,250,$155,450, comprised of proceeds from the issuance of convertible debt in the amount of $87,900,$180,100, offset by payments on convertible debt of $24,650. During the threenine months ended March 31,September 30, 2018, Company had no net cash provided by or usedfinancing activities was $574,732, comprised of proceeds from the issuance of convertible debt in financing activities.the amount of $572,072, offset by payments on convertible debt of $8,050 as well as payments on notes payable of $33,386.

 

Factors That May Affect Future Results

 

Management’s Discussion and Analysis contains information based on management’s beliefs and forward-looking statements that involve a number of risks, uncertainties, and assumptions. There can be no assurance that actual results will not differ materially from the forward-looking statements as a result of various factors, including but not limited to, our ability to obtain the equity funding or borrowings necessary to market and launch our products, our ability to successfully serially produce and market our products; our success establishing and maintaining collaborative licensing and supplier arrangements; the acceptance of our products by customers; our continued ability to pay operating costs; our ability to meet demand for our products; the amount and nature of competition from our competitors; the effects of technological changes on products and product demand; and our ability to successfully adapt to market forces and technological demands of our customers.

 

Recent Accounting Pronouncements

 

The Company has provided a discussion of recent accounting pronouncements in Note 1 to the Condensed Financial Statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not Applicable: the Company is a “smaller reporting company.”

 

 

 

 1917 

 

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to help ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported within the periods specified in the rules and forms of the SEC. This information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation and the requirements of the Exchange Act, our Chief Executive Officer concluded that, as of March 31,September 30, 2019, our disclosure controls and procedures continue to be ineffective. The small size of our Company does not provide for the desired segregation of duty control functions, and we do not have the required level of documentation of our monitoring and control procedures. Currently, our financial constraints prevent us from fully implementing the internal controls prescribed by the Sarbanes-Oxley Act.

 

Changes in Internal Control Over Financial Reporting

 

Management and directors will continue to monitor and evaluate the effectiveness of the Company's internal controls and procedures and the Company's internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow. On March 8, 2019, the Company terminated the Company’s Chief Financial Officer and appointed Dennis M. O’Leary as Chief Financial Officer of the Company. The Company will continue to use outside accounting consultants to assist with the Company’s financial reporting. Otherwise, there have been no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting during the quarter ended March 31,September 30, 2019.

 

 

 

 

 

 

 

 

 2018 

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On March 27, 2019, Thomas A. Cellucci, et al. v. DarkPulse, Inc. et al. (the “Complaint”) was filed in the United States District Court for the Southern District of New York by certain of the Company’s former executive officers, one also being a former director, and a non-employee shareholder (collectively, the “Plaintiffs”), against the Company, its sole officer and director, and others, claiming that the Plaintiffs brought the action to protect their individual rights as minority shareholders, as improperly-ousted officers (other than the non-employee shareholder), and as an improperly-ousted director, seeking equitable relief, damages, recovery of unpaid salaries and other relief. It is the Company's position that the Complaint represents a frivolous harassment lawsuit, and the Company intends to filehas filed a motion to dismiss all claims made in the Complaint and intends to otherwise defend itself vigorously in this matter. The Company is also exploring filing counterclaims against the Plaintiffs in the action.

 

From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on our business, financial condition and operating results.

 

Item 1A. Risk Factors

 

Readers should carefully consider the risks and uncertainties described in ITEM 1A in our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC before deciding whether to invest in shares of our common stock. See also risks discussed above under the section on “Factors That May Affect Future Results” and “Internal Controls”.

 

Our failure to successfully address the risks and uncertainties described in our 2018 Form 10-K would have a material adverse effect on our business, financial condition and/or results of operations, and the trading price of our common stock may decline and investors may lose all or part of their investment. We cannot assure you that we will successfully address these risks or other unknown risks that may affect our business.

 

As an enterprise engaged in the development of new technology, our business is inherently risky.  Our common shares are considered speculative during the development of our new business operations. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the three months ended March 31,September 30, 2019, we had no unregistered sales of equity securities.

 

Item 3. Defaults upon Senior Securities

 

Not Applicable.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

Not Applicable.

 

 

 

 2119 

 

 

Item 6: Exhibits

 

The following exhibits are filed as part of this report:

 

Exhibit

Number

Title of Document
  
31.1Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
32.1Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
  
101.INSXBRL Instance Document
  
101.SCHXBRL Schema Document
  
101.CALXBRL Calculation Linkbase Document
  
101.DEFXBRL Definition Linkbase Document
  
101.LABXBRL Label Linkbase Document
  
101.PREXBRL Presentation Linkbase Document

__________________________

 

 

 

 

 

 

 

 

 2220 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 DARKPULSE, INC.
  
  
Dated: May 17,November 19, 2019By /s/ Dennis M. O’Leary
 Dennis M. O’Leary
 Chief Executive Officer and Chief Financial Officer
 (Principal Executive, Financial and Accounting Officer)

  

 

 

 

 

 

 

 

 

 

 2321